Stock listing
PHIO Stock Price, News, Filings & Events — Phio Pharmaceuticals Corp.
Selected listing: PHIO · BOATS · USD · US
This page tracks Phio Pharmaceuticals Corp.'s PHIO:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PHIO:BOATS. PHIO:BOATS is the stock-level entry point for investors researching Phio Pharmaceuticals Corp., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Phio Pharmaceuticals Corp. (Ticker: PHIO) is a public company based in the United States, focusing on innovative therapies in the pharmaceutical sector. With a market capitalization of approximately $12.08 million, Phio is dedicated to advancing its research and development efforts. The company aims to provide effective treatment solutions through its proprietary technology platform.

- Ticker
- PHIO:BOATS
- Asset type
- Stock
- Market cap
- $12.0M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
Phio Pharmaceuticals Corp. PHIO:BOATS stock context
This page tracks Phio Pharmaceuticals Corp.'s PHIO:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PHIO:BOATS. PHIO:BOATS is the stock-level entry point for investors researching Phio Pharmaceuticals Corp., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Phio Pharmaceuticals Corp. (Ticker: PHIO) is a public company based in the United States, focusing on innovative therapies in the pharmaceutical sector. With a market capitalization of approximately $12.08 million, Phio is dedicated to advancing its research and development efforts. The company aims to provide effective treatment solutions through its proprietary technology platform.
Latest news from Phio Pharmaceuticals Corp.
Phio Announces Key Development Milestone for PH-762 with FDA Submission Supporting Next Stage of Clinical Development in Cutaneous Squamo...
September 14, 2026
Phio Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
September 11, 2026
Phio Pharmaceuticals Secures U.S. Notice of Allowance for INTASYL Composition Selectively Targeting BRD4 Protein with Compound PH-894
August 11, 2026
Phio Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update
August 6, 2026
Correction to Announcement Regarding Phio Pharmaceuticals Participation in the Renmark Financial Communications Live Virtual Non-Deal Roa...
July 22, 2026
Research Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp. investor report
Review AI stock analysis and investor report context for PHIO:BOATS.
Phio Pharmaceuticals Corp. company profile
View the public company page for Phio Pharmaceuticals Corp. on 6ix.
Phio Pharmaceuticals Corp. news
Read company news and market updates connected to Phio Pharmaceuticals Corp..
Phio Pharmaceuticals Corp. investor events
Find investor webinars, events, and replay context for Phio Pharmaceuticals Corp..